2006

The Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting

DAY:
Place：Fort Lauderdale, Florida, U.S.A.
①Pharmacokinetic Profile of Topically Applied Bromfenac Sodium Ophthalmic Solution 0.1% in Subjects Undergoing Cataract Surgery
②Contribution of Calpain to Retinal Pigment Epithelial Cell Damage in Age-Related Macular Degeneration
③Characterization of Lacritin in Human Tears: Comparison to Other Species
④Secretion of Inflammatory Cytokines Induced by Interaction of Corneal Fibroblasts and Polymorphonuclear Leukocytes
⑤Transplantation of Cultivated Corneal Endothelial Sheet in Primates
⑥Reduction of Photoreceptor Cell Death by Calpain Inhibitor SNJ-1945 in N-Methyl-N-Nitrosourea Treated Rats
⑦Computational Simulation of Intraocular Triamcinolone Acetonide After Sub-Tenon Injection
⑧Analysis of Extraocular Behavior of Mucoadhesive Chitosan-Coated Emulsion
⑨Neurite Outgrowth of Cultured Trigeminal Nerve Cells and Reinnervation After Corneal Flap Creation in Rabbit by PACAP27
①T.Ogawa1, K.Miyake2, T.R. McNamara3, J.A. Gow3.
1Global Clinical Development, Senju Pharmaceutical Co., Ltd., Osaka, Japan; 2Shozankai Medical Foundation of the Miyake Eye Clinic, Nagoya, Japan; 3Medical Affairs, ISTA Pharmaceuticals®, Inc., Irvine, CA.
②Y.Tamada1, T.R. Shearer2, M.Azuma1,2.
1Research Laboratory of Ocular Science, Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2Departments of Integrative Biosciences, Oregon Health & Science University, Portland, OR.
③T.Nakajima1, R.D. Walkup2, T.R. Shearer3, M.Azuma1,3.
1Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2Senju Pharmaceutical Co., Ltd., Beaverton, OR; 3Oregon Health & Science University, Portland, OR.
④Y.Nakamura1,2, Y.Lu2, K.Fukuda2, T.-I.Chikama2, N.Kumagai2, T.Nishida2.
1Kobe Creative Center, Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2Biomolecular Recognition & Ophthalmology, Yamaguchi University School of Medicine, Ube, Japan.
⑤N.Koizumi1,2, Y.Sakamoto3, M.Nakamura1,2, N.Okahara4, H.Tsuchiya4, R.Torii4, S.Kinoshita2.
1Research Center for Regenerative Medicine, Doshisha University, Kyoto, Japan; 2Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan; 3Research Business Division, Senju Pharmaceutical Co., Ltd, Osaka, Japan; 4Research Center for Animal Life Science, Shiga University of Medical Science, Ohtsu, Japan.
⑥T.Oka1, T.Nakajima1, T.R. Shearer2, M.Azuma1,2.
1Senju Pharmaceutical Co Ltd, Kobe, Japan; 2Oregon Health & Science University, Portland, OR.
⑦M.Higashiyama1, A.Ohtori1, K.Tojo2.
1Research laboratories, Senju, Kobe, Japan; 2Bioscience and bioinformatics, Kyushu Institute of Technology, Fukuoka, Japan.
⑧M.Yamaguchi1, K.Ueda1, A.Isowaki1, A.Ohtori1, H.Takeuchi2, N.Ohguro3, K.Tojo4.
1Research Laboratories, SENJU pharmaceutical Co., Ltd., Hyogo, Japan; 2Department of Pharmaceutical Engineering, Gifu Pharmaceutical University, Gifu, Japan; 3Department of Ophthalmology, Osaka University Medical School, Osaka, Japan; 4Department of Biochemical Science and Engineering, Kyushu Institute of Technology, Fukuoka, Japan.
⑨C.Yabuta1, Y.Takayama1, T.Nakajima1, Y.Minagawa1, T.R. Shearer2, M.Azuma1,2.
1Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2Integrative Biosciences Department, Oregon Health & Science University, Portland, OR.

Experimental Biology 2006 (EB 2006)

DAY:
Place：San Francisco, CA, U.S.A.
Involvement of calpain in retinal cell death in monkey: Proposed mechanism for glaucoma
E. Nakajima, Takayuki Oka, R.D. Walkup, T.R. Shearer, M.Azuma.

6th International Symposium on Ocular Pharmacology and Therapeutics (6th ISOPT)

DAY:
Place：Berlin, GERMANY
①Ocular Surface Reconstraction Using Tissue Engineering Technique
②Surgical Adjuvant for Visualizing Vitreous Body
③Pharmacologocal Property of Difluprednate, A Novel Strong Steroid in Ophthalmic Use
①S. Kinoshita （Prof. of Kyoto Prefectural Univsity of Medicine. Kyoto, JAPAN）
②T. Sakamoto（Prof. of Kagoshima Univ. Kagoshima, JAPAN）
③H. Sakaki

new | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999